Article
Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies.
Oncotarget - 20 Jun 2015
Brandi Giovanni, Farioli Andrea, Astolfi Annalisa, Biasco Guido, Tavolari Simona
Abstract excerpt
Cholangiocarcinoma (CC) encompasses a group of related but distinct malignancies whose lack of a stereotyped genetic signature makes challenging the identification of genomic landscape and the development of effective targeted therapies. Accumulated evidences strongly suggest that the remarkable genetic heterogeneity of CC may be the result of a complex interplay among different causative factors, some shared by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
